Effect of complex phytoadaptogen on MPTP-induced Parkinson's syndrome in mice

Bulletin of Experimental Biology and Medicine

Volumn 141, Issue 5, 2006, Pages 560-563

  Bocharov, E V ^a   Kucheryanu, V G ^a   Kryzhanovskii, G N ^a   Bocharova, O A ^b   Kudrin, V S ^c   Belorustseva, S A ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Adaptogens; Parkinson's syndrome; Phytomix 40

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; FERROUS ASCORBATE; HOMOVANILLIC ACID; LIPID PEROXIDE; MALONALDEHYDE; PHYTOADAPTOGEN; PHYTOMIX 40; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HOMOGENATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; IN VITRO STUDY; METABOLITE; MOTOR DYSFUNCTION; MOUSE; MUSCLE RIGIDITY; NONHUMAN; PARKINSONISM; SYMPTOM;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; HOMOVANILLIC ACID; LIPID PEROXIDES; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MUSCLE RIGIDITY; PARKINSONIAN DISORDERS; PLANT EXTRACTS; SEROTONIN;

EID: 33747183394     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0220-2     Document Type: Article

References (15)

1. G. N. Kryzhanovskii, I. N. Karaban', S. V. Magaeva, et al., Parkinson's Disease [in Russian], Moscow (2002).
2. V. G. Kucheryanu, Disregulation Pathology [in Russian], Ed. G. N. Kryzhanovskii, Moscow (2002), pp. 515-526.
3. A. S. Attele, J. A. Wu, and C. S. Yuan, Biochem. Pharmacol., 58, 1685-1693 (1999).
4. X. C. Chen, Y. Chen, Y. G. Zhu, et al., Acta Pharmacol. Sin., 23, 829-834 (2002).
5. X. C. Chen, Y. C. Zhou, Y. Chen, et al., Ibid., 26, 56-62 (2005).
6. X. Y. Jiang, J. T. Zhang, and C. Z. Shi, Jao Xue Xue Bao, 31, 321-326 (1996).
7. S. Kim, K. Ahn, T. H. Oh, et al., Biochem. Biophys. Res. Commun., 296, 247-254 (2002).
8. Y. C. Kim, S. R. Kim, G. J. Markelonis, and T. H. Oh, J. Neurosci. Res., 53, 426-432 (1998).
9. Y. H. Kim, K. H. Park, and H. M. Rho, J. Biol. Chem., 271, 24 539-24 543 (1996).
10. D. D. Kitts, A. N. Wijewickreme, and C. Hu, Mol. Cell. Biochem., 203, 1-10 (2000).
11. B. Liao, H. Newmark, and R. Zhou, Exp. Neurol., 173, No. 2, 224-234 (2002).
12. K. Radad, G. Gille, R. Moldzio, et al., J. Neural. Transm., 111, No. 1, 37-45 (2004).
13. A. H. Schapira, M. Gu, J. W. Taanman, et al., Neuroprotection in Parkinson's Disease, Eds. C. W. Olanow, P. Jenner, Kent (1998), pp. 177-188.
14. J. Van Kampen, H. Robertson, T. Hagg, and R. Drobitch, Exp. Neurol., 184, No. 1, 521-529 (2003).
15. W. Xuejiang, T. Magara, and T. Konishi, Free Radic. Res., 31, No. 5, 449-455 (1999).